Vistagen Therapeutics, Inc.'s fasedienol shows promise in treating social anxiety; new results expected 2025. Click for my ...

Recursion is advancing REC-617, a promising reversible, non-covalent CDK7 inhibitor, showing potential in treating advanced solid tumors with positive interim phase 1 data. Read more here.

A study published in the BMJ looks at hormonal contraceptives and the risk of heart attacks and strokes. Dr Sonya Babu-Narayan, Clinical Director at the British Heart Foundation and consultant ...

I remember being super intimidated as a first-year because I felt as though I didn’t know how to start as a pre-med student.

Good morning, everyone, and welcome to the Anavex Life Sciences Fiscal 2025 First Quarter Conference Call. My name is Clint ...

It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...

People who practice cold-water immersion may experience stress reduction after exposure, have a decrease in sickness absences ...

For Tammy Gusher Delgado, 56, the decision to join a clinical trial was clear. With a recent multiple sclerosis diagnosis and a clinical trial offering either the study drug or an approved ...

"NAD plus supplements can help by boosting the body's repair systems, which may reduce wrinkles and other signs of aging over ...

Creatine supplements have been shown to have benefits for women in many stages of life — but it's not recommended for ...

In today’s fast-paced world, eye health often takes a back seat as we navigate through our daily routines filled with screens and artificial lighting. An alarming increase in eye strain, fatigue, and ...

Students can also create tests. They can use artificial intelligence for this. If the notes are handwritten, they type them ...